TELA Bio, Inc. (TELA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 19.06M | 20.87M | 20.69M | 20.2M | 18.52M | 17.65M | 18.96M | 16.09M | 16.6M | 17M | 15.05M | 14.49M |
| Revenue Growth % | 2.91% | 18.24% | 9.14% | 25.52% | 11.55% | 3.83% | 25.94% | 11.02% | 39.42% | 46.26% | 34.89% | 39.28% |
| Cost of Goods Sold | 6.54M | 7.11M | 6.72M | 6.09M | 6.01M | 6.43M | 6.1M | 5.02M | 5.27M | 5.37M | 4.66M | 4.29M |
| COGS % of Revenue | 34.31% | 34.09% | 32.48% | 30.16% | 32.44% | 36.42% | 32.17% | 31.19% | 31.72% | 31.62% | 30.98% | 29.62% |
| Gross Profit | 12.52M | 13.76M | 13.97M | 14.11M | 12.51M | 11.22M | 12.86M | 11.07M | 11.34M | 11.62M | 10.39M | 10.2M |
| Gross Margin % | 65.69% | 65.91% | 67.52% | 69.84% | 67.56% | 63.58% | 67.83% | 68.81% | 68.28% | 68.38% | 69.02% | 70.38% |
| Gross Profit Growth % | 0.06% | 22.58% | 8.64% | 27.38% | 10.37% | -3.47% | 23.77% | 8.55% | 43.53% | 42.17% | 41.95% | 55.74% |
| Operating Expenses | 23.05M | 20.4M | 21.52M | 23.19M | 22.98M | 19.57M | 22.22M | 22.64M | 16.16M | 23.9M | 20.57M | 20.56M |
| OpEx % of Revenue | 120.92% | 97.77% | 104.03% | 114.8% | 124.1% | 110.91% | 117.23% | 140.72% | 97.34% | 140.62% | 136.66% | 141.87% |
| Selling, General & Admin | 20.7M | 18.27M | 19.18M | 20.98M | 20.44M | 17.55M | 20.16M | 20.32M | 21.35M | 21.22M | 18.2M | 18.05M |
| SG&A % of Revenue | 108.63% | 87.57% | 92.68% | 103.89% | 110.39% | 99.42% | 106.32% | 126.28% | 128.59% | 124.82% | 120.93% | 124.53% |
| Research & Development | 2.34M | 2.13M | 2.35M | 2.2M | 2.54M | 2.03M | 2.07M | 2.32M | 2.39M | 2.69M | 2.37M | 2.51M |
| R&D % of Revenue | 12.29% | 10.2% | 11.35% | 10.91% | 13.71% | 11.5% | 10.91% | 14.44% | 14.41% | 15.8% | 15.73% | 17.35% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 |
| Operating Income | -10.53M | -6.65M | -7.55M | -9.08M | -10.47M | -8.35M | -9.37M | -11.57M | -4.83M | -12.28M | -10.18M | -10.36M |
| Operating Margin % | -55.23% | -31.86% | -36.51% | -44.96% | -56.54% | -47.33% | -49.4% | -71.9% | -29.07% | -72.23% | -67.64% | -71.49% |
| Operating Income Growth % | -0.52% | 20.42% | 19.34% | 21.51% | -116.99% | 31.96% | 8.01% | -11.66% | 57.12% | -30.08% | -7.32% | -1.22% |
| EBITDA | -10.53M | -6.65M | -7.31M | -8.81M | -10.21M | -8.09M | -9.1M | -11.32M | -4.59M | -12.12M | -9.96M | -10.15M |
| EBITDA Margin % | -55.23% | -31.86% | -35.31% | -43.63% | -55.1% | -45.83% | -48.01% | -70.36% | -27.66% | -71.28% | -66.19% | -70.02% |
| EBITDA Growth % | -3.15% | 17.8% | 19.73% | 22.17% | -122.23% | 33.25% | 8.64% | -11.56% | 58.4% | -31.25% | -7.34% | -5.53% |
| D&A (Non-Cash Add-back) | 0 | 0 | 248K | 270K | 267K | 266K | 263K | 249K | 234K | 161K | 218K | 214K |
| EBIT | -10.53M | -6.65M | -7.4M | -8.7M | -9.99M | -8.07M | -9.03M | -11.27M | -4.33M | -11.54M | -9.62M | -9.49M |
| Net Interest Income | 2.05M | -1.64M | -1.2M | -1.19M | -1.22M | -1.28M | -1.34M | -1.33M | -1.33M | -1.34M | -1.33M | -1.3M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -2.05M | 1.64M | 1.2M | 1.19M | 1.22M | 1.28M | 1.34M | 1.33M | 1.33M | 1.34M | 1.33M | 1.3M |
| Other Income/Expense | -1.69M | -2.25M | -1.05M | -809K | -740K | -998K | -1.01M | -1.03M | -835K | -612K | -776K | -428K |
| Pretax Income | -12.21M | -8.9M | -8.6M | -9.89M | -11.21M | -9.35M | -10.37M | -12.6M | -5.66M | -12.89M | -10.96M | -10.79M |
| Pretax Margin % | -64.08% | -42.63% | -41.58% | -48.97% | -60.54% | -52.99% | -54.71% | -78.3% | -34.1% | -75.83% | -72.79% | -74.44% |
| Income Tax | 60K | 145K | 0 | 33K | 52K | -144K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.49% | -1.63% | 0% | -0.33% | -0.46% | 1.54% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -12.27M | -9.04M | -8.6M | -9.92M | -11.26M | -9.21M | -10.37M | -12.6M | -5.66M | -12.89M | -10.96M | -10.79M |
| Net Margin % | -64.39% | -43.32% | -41.58% | -49.13% | -60.82% | -52.17% | -54.71% | -78.3% | -34.1% | -75.83% | -72.79% | -74.44% |
| Net Income Growth % | -8.96% | 1.81% | 17.06% | 21.25% | -98.98% | 28.56% | 5.34% | -16.77% | 52.93% | -29.17% | -2.27% | 15.31% |
| Net Income (Continuing) | -12.27M | -9.04M | -8.6M | -9.92M | -11.26M | -9.21M | -10.37M | -12.6M | -5.66M | -12.89M | -10.96M | -10.79M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.21 | -0.17 | -0.19 | -0.22 | -0.25 | -0.23 | -0.42 | -0.51 | -0.23 | -0.53 | -0.45 | -0.46 |
| EPS Growth % | 16% | 26.09% | 54.76% | 56.86% | -8.7% | 56.6% | 6.67% | -10.87% | 68.49% | -3.92% | 36.62% | 50% |
| EPS (Basic) | -0.21 | -0.17 | -0.19 | -0.22 | -0.25 | -0.23 | -0.42 | -0.51 | -0.23 | -0.53 | -0.45 | -0.46 |
| Diluted Shares Outstanding | 57.26M | 51.68M | 45.42M | 45.37M | 45.27M | 40.07M | 24.7M | 24.66M | 24.58M | 24.49M | 24.48M | 23.24M |
| Basic Shares Outstanding | 57.26M | 51.68M | 45.42M | 45.37M | 45.27M | 40.07M | 24.7M | 24.66M | 24.58M | 24.49M | 24.48M | 23.24M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |